FcR Therapeutics is developing first-in-class antibody solutions for autoimmune disease.

We believe that our proprietary drug leads can target Fc receptors (FcRs), a specific class of receptors expressed on various immune cells, to provide a major therapeutic perspective for patients suffering from various devastating autoimmune diseases.

We provide proprietary antibody solutions aiming to disrupt the overactive interplay between autoantibodies and Fc receptors resulting in inflammation and tissue damage.

Our therapeutic focus is on autoimmune diseases that can benefit from interfering with derailed Fc-receptor biology by developing a risk-balanced and diverse pipeline of unique proprietary drugs, resulting in potent and safe therapeutic options.

FcR Therapeutics

Org chart

Teams

Offices